5 completed, 3 recruiting, 2 terminated, 2 unknown. 8 Not applicable, 3 Phase 2, 2 Phase 1, 1 Phase 3.
Follow Skin Neoplasm: new trials by email Literature Review of Skin Neoplasm trials Research Report on Skin Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital Serious Illness Conversation Program training, ACS Geriatric Surgery Verification Program Implementation - Breast Carcinoma, Malignant Digestive System Neoplasm | Not applicable | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 4000 | 2026-11-15 | 2026-07-23 |
| Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions Quantitative Oblique Back-Illumination Microscopy, Radiation Therapy - Malignant Skin Neoplasm, Skin Disorder | Not applicable | Recruiting | Emory University | 10 | 2025-10-15 | 2025-12-16 |
| Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Malignant Skin Neoplasm, Metastatic Malignant Soft Tissue Neoplasm | Not applicable | Recruiting | Mayo Clinic | 60 | 2025-08-11 | 2026-09-11 |
| Impact of Sunscreen Dispensers in Parks Visited by Teenagers Dispensers, Flyers, Enhanced Signage + a social media component delivered by teen ambassadors - Skin Neoplasm, Adolescent Behavior | Not applicable | Active not recruiting | Harvard School of Public Health (HSPH) | 1200 | 2023-06-03 | 2024-10-18 |
| DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations Trastuzumab, Pertuzumab - Haematological Malignancy, Colorectal Neoplasms | Phase 2 / Phase 3 | Recruiting | Cancer Research UK | 30 | 2023-03-07 | 2025-12-02 |
| Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT high-resolution PET-CT specimen imaging. - Head and Neck Neoplasms, Thyroid Neoplasm | Not applicable | Completed | University Hospital, Ghent | 9 | 2020-08-28 | 2022-11-30 |
| PLANNED VISUAL EDUCATION ABOUT SKIN CANCER Planned Visual Education Based on Health Belief Model - Skin Neoplasm | Not applicable | Completed | Manisa Celal Bayar University | 116 | 2019-02-01 | 2023-06-15 |
| Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance Pembrolizumab, Cetuximab - Skin Neoplasm | Phase 2 | Unknown | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 43 | 2018-10-01 | 2018-09-11 |
| EPR Tumor Oximetry With CE India Ink Carlo Erba Ink Injection, EPR Oximetry Measurement - Neoplasms, Malignant, Breast Neoplasm | Terminated | Philip Schaner | 3 | 2017-08-30 | 2019-12-19 | |
| 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients 131I-Tenatumomab - Breast Neoplasm, Head and Neck Neoplasm | Phase 1 | Terminated | sigma-tau i.f.r. S.p.A. | 2 | 2015-11-01 | 2018-09-18 |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma ASN-002, 5-FU - Basal Cell Nevus Syndrome, Skin Neoplasm | Phase 1 / Phase 2 | Completed | Ascend Biopharmaceuticals Ltd | 16 | 2015-09-01 | 2018-06-06 |
| Utility of the Skin Cancer Quality of Life Impact Tool SCQOLIT questionnaire - Skin Neoplasm, Squamous Cell Carcinoma | Not applicable | Completed | Oxford University Hospitals NHS Trust | 318 | 2015-07-01 | 2020-12-17 |
| School-based Randomized Trial of SunSmart Interventions UV Dosimetry Laboratory - Skin Neoplasm | Not applicable | Completed | University of Southern California | 3750 | 2014-01-01 | 2019-11-27 |
| Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions Malignant Melanoma, Pigmented Nevi | Unknown | Hadassah Medical Organization | 20 | 2010-07-01 | 2018-08-02 |
Skin Neoplasms (14) · Head and Neck Neoplasms (4) · Breast Neoplasms (3) · Carcinoma, Basal Cell (2) · Carcinoma, Squamous Cell (2) · Melanoma (2) · Neoplasms (2) · Pancreatic Neoplasms (2) · Soft Tissue Neoplasms (2) · Urogenital Neoplasms (2) · Adolescent Behavior (1) · Anthrax (1) · Basal Cell Nevus Syndrome (1) · Central Nervous System Neoplasms (1) · Colorectal Neoplasms (1)
Neoplasms by Site (14) · Skin and Connective Tissue Diseases (14) · Skin Diseases (13) · Neoplasms (12) · Neoplasms by Histologic Type (6) · Endocrine System Diseases (4) · Breast Diseases (3) · Carcinoma (3) · Digestive System Diseases (3) · Endocrine Gland Neoplasms (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Neoplasms, Basal Cell (3) · Neoplasms, Glandular and Epithelial (3)
Biopsy (1) · Cetuximab (1) · Fluorouracil (1) · Radiation (1) · Radiotherapy (1) · Specimen Handling (1) · Trastuzumab (1) · gusacitinib (1) · pembrolizumab (1) · pertuzumab (1)
Ascend Biopharmaceuticals Ltd (1) · Cancer Research UK (1) · Emory University (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Hadassah Medical Organization (1) · Harvard School of Public Health (HSPH) (1) · Manisa Celal Bayar University (1) · Mayo Clinic (1) · Ohio State University Comprehensive Cancer Center (1) · Oxford University Hospitals NHS Trust (1) · Philip Schaner (1) · University Hospital, Ghent (1) · University of Southern California (1) · sigma-tau i.f.r. S.p.A. (1)
United States (5) · Italy (2) · United Kingdom (2) · Australia (1) · Belgium (1) · France (1) · Israel (1) · Turkey (Türkiye) (1)
Alan Geller, MPH, RN (1) · Gregory Siller (1) · Lynda Spelman (1) · Matthew Krebs, Dr (1) · Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR (1) · Myles G Cockburn, PhD (1) · Paolo Bossi, MD (1) · Philip E Schaner, M.D., Ph.D. (1) · Rodney Sinclair (1) · Rubeta N Matin (1) · Samilia Obeng-Gyasi, MD, MPH (1) · Scott C. Lester, MD (1) · Wouter Huvenne, MD, PhD (1)
PMID 10790938, PMID 12553634, PMID 20473901, PMID 20570081, PMID 21612915, PMID 23039760, PMID 23244101, PMID 23806094, PMID 24223037, PMID 24508292, PMID 24958589, PMID 25310749, PMID 25821026, PMID 26773419, PMID 27155664, PMID 28229313, PMID 31572761, PMID 33971211, PMID 34442033, PMID 36854863, PMID 40465956
2014 (1), P01CA190193 (1), P30CA138292 (1)